Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
CR-9114 by Leyden Laboratories for Influenzavirus A Infections: Likelihood of Approval
CR-9114 is under clinical development by Leyden Laboratories and currently in Phase II for Influenzavirus A Infections. According to GlobalData,...
Data Insights
CR-9114 by Leyden Laboratories for Influenza A Virus, H3N2 Subtype Infections: Likelihood of Approval
CR-9114 is under clinical development by Leyden Laboratories and currently in Phase II for Influenza A Virus, H3N2 Subtype Infections....